Want to track ANVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Annovis Bio, Inc. (ANVS) Statistics
Valuation metrics
Market Cap 36M
Enterprise value 22.96M
Trailing P/E (ttm) -1.29
Forward P/E -1.92
PEG ratio -0.15
Price/Sales (ttm) -
Price/Book (mrq) 16.84
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.55
Overview
Shares outstanding 28.54M
Float 24.58M
Shares short 4.82M
% Held by insiders 0.14%
% Held by institutions 0.17%
Average volume (10 days) 1.38M
Average volume (90 days) 1.07M
Price summary
52-Week low 1.54
52-Week high 5.5
Beta 1.26
50-Day moving average 2.05
200-Day moving average 2.82
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -2.52%
Return on equity -3.18%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -40.92M
Diluted EPS (ttm) -1.47
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 14.22M
Total cash per share (mrq) 0.51
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.27%
Book value per share (mrq) 0.11
Cash Flow
Cash flow statement -26.77M
Levered free cash flow (LFCF) -28.85M
